Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

The study suggests that hypothyroidism may cause alopecia areata.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Different types of sun exposure damage skin cells and immune cells, with chronic exposure leading to more severe and lasting damage.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Treating skin conditions with both psychological and dermatological care improves patient outcomes and can save costs.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Visible light can damage skin and most sunscreens don't block it well; more research is needed on its effects and protection methods.

The document concludes that there have been significant improvements in diagnosing and treating skin diseases, including melanoma, with new techniques and therapies.

Pure carbon nanotubes are safe for mice, but impure ones cause immune issues and hair loss.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.